Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis

Παρόμοια τεκμήρια

• Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
  ανά: Nemiche, O, κ.ά.
  Έκδοση: (2011)
• Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
  ανά: Alexeeva, E, κ.ά.
  Έκδοση: (2011)
• Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry
  ανά: Horneff, Gerd, κ.ά.
  Έκδοση: (2017)
• Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data
  ανά: De Benedetti, F, κ.ά.
  Έκδοση: (2011)
• 2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
  ανά: Yokota, S, κ.ά.
  Έκδοση: (2008)